Industry News

FDA Approves NeuroGenetic Pharmaceuticals Application to Begin Clinical Trials for Its NGP 555 Compound to Treat and Prevent Alzheimer�s Disease
Molecular Detection of Colon Cancer
FDA Approves Stendra sNDA
FDA warns doctors to beware fake drug distributors
FDA warns doctors to beware fake drug distributors
FDA Approves Stendra sNDA
AHF Joins National Coalition on Health Care's 'Campaign for Sustainable Rx Pricing' Pharmaceutical Companies
Five Defendants Sentenced to Prison Terms for Multi-Million-Dollar Theft of Pre-Retail Medical Products
Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE VIABAHN Endoprosthesis
NovaDel Announces the Sale of Its ZolpiMist New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC
Foster Delivery Science To Build Facility For Manufacturing Drug Delivery Polymers
Minerva Neurosciences Announces Completion of FDA Review of Investigational New Drug Application for MIN-202 and Plans for First U.S.-Based Clinical Trial Bioavailability Study in U.S. for Investigational Therapy in Development for Treatment of Insomnia t
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
NovaDel Announces the Sale of Its ZolpiMist� New Drug Application, License and Intellectual Property to Amherst Pharmaceuticals, LLC
Gore Receives FDA Approval for Endovascular Treatment of In-Stent Restenosis with the GORE� VIABAHN� Endoprosthesis
Merck Gets FDA Approval of Keytruda
Auxilium Pharma rejects Endo's takeover offer
Auxilium Pharma rejects Endo's takeover offer
Clinical Network Services (CNS) and Ventac Partners Sign Cooperative Partnership
Lundbeck Introduces NORTHERA (droxidopa) Capsules in the U.S. for Symptomatic Neurogenic Orthostatic Hypotension
ACADIA Pharmaceuticals Secures FDA Breakthrough Therapy Designation for NUPLAZID for Parkinson's Disease Psychosis
Ipsen Secures FDA Priority Review for Somatuline in Treatment of GEP- NETs in U.S.
Taxes and subsidies could encourage healthier diet and lower healthcare costs Tufts University, Health Sciences Campus
FDA Approves the Use of a Needle-Free Injection Device to Administer the Influenza Vaccine
Soligenix Awarded NIAID Contract Valued up to $24.7 Million for the Development of Heat Stable RiVax Vaccine